96 related articles for article (PubMed ID: 3262485)
1. Effect of smoking on natural killer cell activity in the lung.
Takeuchi M; Nagai S; Izumi T
Chest; 1988 Oct; 94(4):688-93. PubMed ID: 3262485
[TBL] [Abstract][Full Text] [Related]
2. OK-432 and IL-2-augmented cytotoxicity of human natural killer cells and cytotoxic T lymphocytes at the clonal level.
Gravekamp C; Vreugdenhil R; Bolhuis RL
FEMS Microbiol Immunol; 1988 Jan; 1(1):31-9. PubMed ID: 2978812
[TBL] [Abstract][Full Text] [Related]
3. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432.
Wakasugi H; Kasahara T; Minato N; Hamuro J; Miyata M; Morioka Y
J Natl Cancer Inst; 1982 Oct; 69(4):807-12. PubMed ID: 6181282
[TBL] [Abstract][Full Text] [Related]
4. Natural killer activity is present in rat lung lavage and inhibited by lidocaine.
Renzi PM; Ginns LC
Immunopharmacol Immunotoxicol; 1990; 12(3):389-415. PubMed ID: 2266229
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of lung natural killer cell activity by smoking: the role of alveolar macrophages.
Takeuchi M; Nagai S; Nakajima A; Shinya M; Tsukano C; Asada H; Yoshikawa K; Yoshimura M; Izumi T
Respiration; 2001; 68(3):262-7. PubMed ID: 11416246
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of inhibition of alveolar macrophages on autologous blood natural killer cell activity.
Takeuchi M; Nagai S; Izumi T
Chest; 1989 Feb; 95(2):383-7. PubMed ID: 2492465
[TBL] [Abstract][Full Text] [Related]
7. Enhanced generation of OK-432-induced killer cells by interleukin 2.
Ujiie T
Jpn J Exp Med; 1987 Jun; 57(3):183-8. PubMed ID: 3500332
[TBL] [Abstract][Full Text] [Related]
8. Lymphokine-activated killer cell activity in lung cancer.
LeFever A; Funahashi A
Chest; 1991 Feb; 99(2):292-7. PubMed ID: 1989785
[TBL] [Abstract][Full Text] [Related]
9. In vivo boosting of lung natural killer and lymphokine-activated killer cell activity by interleukin-2: comparison of systemic, intrapleural and inhalation routes.
Flexman JP; Manning LS; Robinson BW
Clin Exp Immunol; 1990 Oct; 82(1):151-6. PubMed ID: 2208789
[TBL] [Abstract][Full Text] [Related]
10. Lung natural killer and interleukin-2 activity in lung cancer. A pulmonary compartment of augmented natural killer activity occurs in patients with bronchogenic carcinoma.
Pitchenik AE; Guffee J; Stein-Streilein J
Am Rev Respir Dis; 1987 Dec; 136(6):1327-32. PubMed ID: 3500659
[TBL] [Abstract][Full Text] [Related]
11. Bronchoalveolar lavage fluid and blood natural killer and natural killer T-like cells in cryptogenic organizing pneumonia.
Papakosta D; Manika K; Gounari E; Kyriazis G; Kontakiotis T; Spyropoulos G; Kontakioti E; Zarogoulidis K
Respirology; 2014 Jul; 19(5):748-54. PubMed ID: 24889556
[TBL] [Abstract][Full Text] [Related]
12. Augmentation in cytotoxicity of lymphnode lymphocytes by OK-432.
Tanaka N; Gotoh K; Kobayashi G; Gouchi A; Orita K
Int J Immunopharmacol; 1994 Feb; 16(2):131-5. PubMed ID: 8181902
[TBL] [Abstract][Full Text] [Related]
13. Studies of natural killer activity and augmentation by OK-432 in patients with gynecological malignancies.
Negishi Y; Miura M; Saito M; Sano Y; Akiya K; Fujiwara Y
Gynecol Obstet Invest; 1986; 21(1):40-6. PubMed ID: 3485072
[TBL] [Abstract][Full Text] [Related]
14. [Observation on natural killer cell activity in gastric cancer patients and effect of nonspecific immunopotentiator administration on its postoperative reduction].
Oshita H; Saji S; Sugiyama Y; Tanemura H; Sakata K; Tanaka S; Ito T
Nihon Geka Gakkai Zasshi; 1985 Oct; 86(10):1417-25. PubMed ID: 4079897
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2.
Zhang SR; Salup RR; Urias PE; Twilley TA; Talmadge JE; Herberman RB; Wiltrout RH
Cancer Immunol Immunother; 1986; 21(1):19-25. PubMed ID: 3484675
[TBL] [Abstract][Full Text] [Related]
16. [Deep lung--cellular reaction to HIV].
Tavares Marques MA; Alves V; Duque V; Botelho MF
Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
[TBL] [Abstract][Full Text] [Related]
17. Modulation of natural killer cell function by human alveolar macrophages.
Weissman DN; deShazo RD; Banks DE
J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 1):571-7. PubMed ID: 3490501
[TBL] [Abstract][Full Text] [Related]
18. Natural killer (NK) cell activating factor released from murine thymocytes stimulated with an anti-tumor streptococcal preparation, OK-432.
Shitara K; Ichimura O; Mitsuno T; Osawa T
J Immunol; 1985 Feb; 134(2):1039-47. PubMed ID: 2578148
[TBL] [Abstract][Full Text] [Related]
19. Human pulmonary natural killer (NK) cells exhibit limited lymphokine-activated killer (LAK) activity.
Yarbrough WC; Weissler JC
Am J Respir Cell Mol Biol; 1989 Oct; 1(4):305-11. PubMed ID: 2483121
[TBL] [Abstract][Full Text] [Related]
20. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1607-15. PubMed ID: 2809385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
